NURS 6521 Final Exam / NURS6521 Final Exam:
Advanced Pharmacology (Latest 2022)|
Walden University | Complete Solution
Section 1: Pharmacokinetics and Pharmacodynamics (Questions 1–25)
Question 1
A nurse practitioner is educating a patient about why their oral medication requires a higher
dose than the same drug given intravenously. The NP explains that the oral dose is partially
metabolized in the liver before reaching systemic circulation. Which pharmacokinetic process
does this describe?
A. Volume of distribution
B. First-pass metabolism
C. Phase II conjugation
D. Protein binding
Correct Answer: B. First-pass metabolism
Rationale: First-pass metabolism refers to the pre-systemic metabolism of a drug by the
liver after oral absorption but before it reaches systemic circulation, significantly reducing
bioavailability . Drugs with high first-pass metabolism (e.g., propranolol, morphine) require
higher oral doses to achieve therapeutic effects. Volume of distribution describes how a drug
distributes throughout body compartments. Phase II conjugation is a metabolic pathway, not an
absorption phenomenon.
Question 2
A patient with chronic kidney disease is prescribed a medication that is primarily eliminated by
glomerular filtration. The nurse practitioner anticipates that the drug will require dosage
adjustment. Which pharmacokinetic parameter is most affected by decreased renal function?
A. Absorption rate
B. Volume of distribution
C. Half-life
D. Protein binding
, Correct Answer: C. Half-life
Rationale: Half-life is the pharmacokinetic parameter most directly affected by decreased
renal function for drugs eliminated primarily by glomerular filtration or tubular secretion . When
renal clearance decreases, the elimination rate constant decreases, prolonging the half-life and
potentially leading to drug accumulation and toxicity. Absorption rate is unaffected by renal
function. Volume of distribution may change slightly but is less impactful.
Question 3
A nurse practitioner is prescribing a medication that is a CYP3A4 substrate to a patient who
consumes grapefruit juice daily. The NP expects which pharmacokinetic change?
A. Decreased drug metabolism and increased plasma levels
B. Increased drug metabolism and decreased plasma levels
C. No effect on drug metabolism
D. Enhanced renal excretion of the drug
Correct Answer: A. Decreased drug metabolism and increased plasma levels
Rationale: Grapefruit juice is a CYP3A4 inhibitor that decreases the metabolism of CYP3A4
substrates, leading to increased plasma drug levels and potential toxicity . CYP3A4 metabolizes
more than 50% of all drugs. This interaction is clinically significant for drugs such as statins,
calcium channel blockers, and benzodiazepines. Inducers like rifampin would have the opposite
effect.
Question 4
A patient with a known genetic polymorphism of CYP2D6 is classified as a poor metabolizer. The
NP prescribes codeine for pain management. What clinical outcome is most likely?
A. Enhanced pain relief due to higher morphine levels
B. No analgesic effect because codeine cannot be converted to its active metabolite
C. Increased risk of serotonin syndrome
D. Rapid clearance of codeine with subtherapeutic levels
Correct Answer: B. No analgesic effect because codeine cannot be converted to its active
metabolite
, Rationale: Codeine is a prodrug that requires conversion to morphine via CYP2D6 to
produce analgesia . A CYP2D6 poor metabolizer cannot efficiently convert codeine to its active
metabolite, resulting in little to no pain relief. Ultra-rapid metabolizers would have the opposite
problem, producing excessive morphine and increased toxicity risk.
Question 5
A drug has a narrow therapeutic index, and the NP needs to monitor serum drug levels to
ensure efficacy while preventing toxicity. Which medication requires therapeutic drug
monitoring?
A. Amoxicillin
B. Lithium
C. Acetaminophen
D. Hydrochlorothiazide
Correct Answer: B. Lithium
Rationale: Lithium has a narrow therapeutic index and requires routine serum level
monitoring to prevent toxicity while ensuring efficacy . Drugs with narrow therapeutic indices
(e.g., warfarin, digoxin, phenytoin, lithium) require therapeutic drug monitoring because small
changes in plasma concentration can lead to therapeutic failure or toxicity.
Question 6
A 68-year-old patient with cirrhosis and hypoalbuminemia is prescribed a highly protein-bound
medication. The nurse practitioner understands that the free (active) drug concentration will be:
A. Decreased due to increased protein binding capacity
B. Increased due to reduced albumin available for protein binding
C. Unchanged because protein binding does not affect free drug levels
D. Decreased because the liver cannot metabolize the drug
Correct Answer: B. Increased due to reduced albumin available for protein binding
Rationale: In hypoalbuminemia (e.g., cirrhosis), there is less albumin available to bind the
drug . Because only free (unbound) drug is pharmacologically active, a decrease in protein
binding leads to an increase in free drug concentration, potentially increasing both therapeutic
and toxic effects.
, Question 7
A drug with a half-life of 6 hours is administered intravenously. Approximately how long will it
take to reach steady state?
A. 12 hours
B. 18 hours
C. 30 hours
D. 48 hours
Correct Answer: C. 30 hours
Rationale: Steady state is reached after approximately 4–5 half-lives. With a half-life of 6
hours, 5 × 6 = 30 hours . At steady state, the rate of drug administration equals the rate of drug
elimination. Understanding half-life is essential for determining dosing intervals.
Question 8
Which route of administration completely bypasses first-pass metabolism?
A. Oral
B. Intravenous
C. Rectal
D. Sublingual
Correct Answer: B. Intravenous
Rationale: Intravenous administration delivers drug directly into the bloodstream,
completely avoiding first-pass hepatic metabolism and resulting in 100% bioavailability . While
sublingual and rectal routes partially avoid first-pass metabolism, only IV administration
bypasses it entirely.
Question 9
A patient is prescribed a medication that is a weak base. Which statement best describes the
absorption of this medication in the stomach (pH 1.5)?
A. The medication will be non-ionized and well absorbed
B. The medication will be ionized and poorly absorbed
Advanced Pharmacology (Latest 2022)|
Walden University | Complete Solution
Section 1: Pharmacokinetics and Pharmacodynamics (Questions 1–25)
Question 1
A nurse practitioner is educating a patient about why their oral medication requires a higher
dose than the same drug given intravenously. The NP explains that the oral dose is partially
metabolized in the liver before reaching systemic circulation. Which pharmacokinetic process
does this describe?
A. Volume of distribution
B. First-pass metabolism
C. Phase II conjugation
D. Protein binding
Correct Answer: B. First-pass metabolism
Rationale: First-pass metabolism refers to the pre-systemic metabolism of a drug by the
liver after oral absorption but before it reaches systemic circulation, significantly reducing
bioavailability . Drugs with high first-pass metabolism (e.g., propranolol, morphine) require
higher oral doses to achieve therapeutic effects. Volume of distribution describes how a drug
distributes throughout body compartments. Phase II conjugation is a metabolic pathway, not an
absorption phenomenon.
Question 2
A patient with chronic kidney disease is prescribed a medication that is primarily eliminated by
glomerular filtration. The nurse practitioner anticipates that the drug will require dosage
adjustment. Which pharmacokinetic parameter is most affected by decreased renal function?
A. Absorption rate
B. Volume of distribution
C. Half-life
D. Protein binding
, Correct Answer: C. Half-life
Rationale: Half-life is the pharmacokinetic parameter most directly affected by decreased
renal function for drugs eliminated primarily by glomerular filtration or tubular secretion . When
renal clearance decreases, the elimination rate constant decreases, prolonging the half-life and
potentially leading to drug accumulation and toxicity. Absorption rate is unaffected by renal
function. Volume of distribution may change slightly but is less impactful.
Question 3
A nurse practitioner is prescribing a medication that is a CYP3A4 substrate to a patient who
consumes grapefruit juice daily. The NP expects which pharmacokinetic change?
A. Decreased drug metabolism and increased plasma levels
B. Increased drug metabolism and decreased plasma levels
C. No effect on drug metabolism
D. Enhanced renal excretion of the drug
Correct Answer: A. Decreased drug metabolism and increased plasma levels
Rationale: Grapefruit juice is a CYP3A4 inhibitor that decreases the metabolism of CYP3A4
substrates, leading to increased plasma drug levels and potential toxicity . CYP3A4 metabolizes
more than 50% of all drugs. This interaction is clinically significant for drugs such as statins,
calcium channel blockers, and benzodiazepines. Inducers like rifampin would have the opposite
effect.
Question 4
A patient with a known genetic polymorphism of CYP2D6 is classified as a poor metabolizer. The
NP prescribes codeine for pain management. What clinical outcome is most likely?
A. Enhanced pain relief due to higher morphine levels
B. No analgesic effect because codeine cannot be converted to its active metabolite
C. Increased risk of serotonin syndrome
D. Rapid clearance of codeine with subtherapeutic levels
Correct Answer: B. No analgesic effect because codeine cannot be converted to its active
metabolite
, Rationale: Codeine is a prodrug that requires conversion to morphine via CYP2D6 to
produce analgesia . A CYP2D6 poor metabolizer cannot efficiently convert codeine to its active
metabolite, resulting in little to no pain relief. Ultra-rapid metabolizers would have the opposite
problem, producing excessive morphine and increased toxicity risk.
Question 5
A drug has a narrow therapeutic index, and the NP needs to monitor serum drug levels to
ensure efficacy while preventing toxicity. Which medication requires therapeutic drug
monitoring?
A. Amoxicillin
B. Lithium
C. Acetaminophen
D. Hydrochlorothiazide
Correct Answer: B. Lithium
Rationale: Lithium has a narrow therapeutic index and requires routine serum level
monitoring to prevent toxicity while ensuring efficacy . Drugs with narrow therapeutic indices
(e.g., warfarin, digoxin, phenytoin, lithium) require therapeutic drug monitoring because small
changes in plasma concentration can lead to therapeutic failure or toxicity.
Question 6
A 68-year-old patient with cirrhosis and hypoalbuminemia is prescribed a highly protein-bound
medication. The nurse practitioner understands that the free (active) drug concentration will be:
A. Decreased due to increased protein binding capacity
B. Increased due to reduced albumin available for protein binding
C. Unchanged because protein binding does not affect free drug levels
D. Decreased because the liver cannot metabolize the drug
Correct Answer: B. Increased due to reduced albumin available for protein binding
Rationale: In hypoalbuminemia (e.g., cirrhosis), there is less albumin available to bind the
drug . Because only free (unbound) drug is pharmacologically active, a decrease in protein
binding leads to an increase in free drug concentration, potentially increasing both therapeutic
and toxic effects.
, Question 7
A drug with a half-life of 6 hours is administered intravenously. Approximately how long will it
take to reach steady state?
A. 12 hours
B. 18 hours
C. 30 hours
D. 48 hours
Correct Answer: C. 30 hours
Rationale: Steady state is reached after approximately 4–5 half-lives. With a half-life of 6
hours, 5 × 6 = 30 hours . At steady state, the rate of drug administration equals the rate of drug
elimination. Understanding half-life is essential for determining dosing intervals.
Question 8
Which route of administration completely bypasses first-pass metabolism?
A. Oral
B. Intravenous
C. Rectal
D. Sublingual
Correct Answer: B. Intravenous
Rationale: Intravenous administration delivers drug directly into the bloodstream,
completely avoiding first-pass hepatic metabolism and resulting in 100% bioavailability . While
sublingual and rectal routes partially avoid first-pass metabolism, only IV administration
bypasses it entirely.
Question 9
A patient is prescribed a medication that is a weak base. Which statement best describes the
absorption of this medication in the stomach (pH 1.5)?
A. The medication will be non-ionized and well absorbed
B. The medication will be ionized and poorly absorbed
